3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
3
Colonic Neoplasms
2
Turcot syndrome
1
Recurrence
1
Oropharyngeal Neoplasms
1
Mouth Neoplasms
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Glioma
1
Carcinoma
1
Interventions
pembrolizumab
4
Nivolumab
2
toripalimab
1
relatlimab
1
fludarabine phosphate
1
fludarabine
1
denileukin diftitox
1
Specimen Handling
1
Magnetic Resonance Spectroscopy
1
Irinotecan
1
Ipilimumab
1
E7777 fusion protein
1
Diffusion Tensor Imaging
1
DNA Mismatch Repair
1
Cyclophosphamide
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Turcot syndrome
×
Celecoxib
×
90 days
×
Clear all
NCT06903858
2026-05-22
PICC-3
Sun Yat-sen University
Phase 2
Recruiting
105 enrolled